EVOLUS, INC. Paid-in-Kind Interest
EVOLUS, INC. (EOLS) reported Paid-in-Kind Interest of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2022-11-08
- EVOLUS, INC. paid-in-kind interest for the quarter ending 2022-09-30 was $0.00.
- EVOLUS, INC. paid-in-kind interest for the quarter ending 2022-06-30 was $0.00.
- EVOLUS, INC. paid-in-kind interest for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- EVOLUS, INC. paid-in-kind interest for the quarter ending 2021-12-31 was -$272.00K, a 189.77% decline year-over-year.
- EVOLUS, INC. paid-in-kind interest for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- EVOLUS, INC. paid-in-kind interest for fiscal 2020 was $506.00K.
- EVOLUS, INC. paid-in-kind interest for fiscal 2019 was $0.00.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$272.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | -$272.00K derived: sum of 3 quarters · filed 2022-08-02 | -$273.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | -$272.00K derived: sum of 2 quarters · filed 2022-05-10 | -$273.00K derived: sum of 3 quarters · filed 2022-11-08 | -$273.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$273.00K derived: sum of 2 quarters · filed 2022-11-08 | -$273.00K derived: sum of 3 quarters · filed 2022-11-08 | $0.00 10-K · filed 2022-03-03 |
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.00K derived: sum of 2 quarters · filed 2022-11-08 | $272.00K 10-Q · filed 2022-11-08 | $575.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $273.00K 10-Q · filed 2022-08-02 | $576.00K derived: sum of 3 quarters · filed 2022-08-02 | $779.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $273.00K 10-Q · filed 2022-05-10 | $576.00K derived: sum of 2 quarters · filed 2022-05-10 | $779.00K derived: sum of 3 quarters · filed 2022-05-10 | $779.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $506.00K derived: sum of 2 quarters · filed 2022-03-03 | $506.00K derived: sum of 3 quarters · filed 2022-03-03 | $506.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $203.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $203.00K derived: sum of 2 quarters · filed 2021-11-02 | $203.00K 10-Q · filed 2021-11-02 | $203.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $0.00 10-Q · filed 2021-08-04 | $0.00 derived: sum of 3 quarters · filed 2021-08-04 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | $0.00 derived: sum of 2 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |